Top

Published in:

01-12-2019 | Smelling Disorder | Original Communication

Specific intranasal and central trigeminal electrophysiological responses in Parkinson’s disease

Authors: Cécilia Tremblay, Rosa Emrich, Annachiara Cavazzana, Lisa Klingelhoefer, Moritz D. Brandt, Thomas Hummel, Antje Haehner, Johannes Frasnelli

Published in: Journal of Neurology | Issue 12/2019

Abstract

Olfactory dysfunction is a frequent early non-motor symptom of Parkinson’s disease (PD). There is evidence that with regard to trigeminal perception, PD-related olfactory dysfunction is different from other olfactory disorders. More specifically, trigeminal sensitivity, when measured behaviorally, was unimpaired in PD patients as opposed to patients with non-Parkinsonian olfactory dysfunction (NPOD). We sought to investigate the trigeminal pathway by measuring electrophysiological recordings from the nasal epithelium and EEG-derived event-related potentials in response to a specific trigeminal stimulus in 21 PD patients and compare them to 23 patients with NPOD and 25 controls (C). The peripheral trigeminal response, as measured by the negative-mucosa potential, showed no difference between patients with PD and controls whereas PD patients showed faster responses than patients with NPOD, the latter having shown slower and larger responses than controls (18 PD, 14 NPOD, 20 C). The central trigeminal response, as measured by event-related potentials, revealed larger early component response in PD patients compared to patients with NPOD (15 PD, 21 NPOD, 23 C). As expected, psychophysical olfactory testing showed impaired olfactory function in both groups of patients as opposed to controls. Discriminant analysis revealed a model that could predict group membership for 80% of participants based on the negative-mucosa potential latency, olfactory threshold and discrimination tests. These results provide novel insights into the pattern of trigeminal activation in PD which will help to differentiate PD-related olfactory loss from NPOD, a crucial step towards establishing early screening batteries for PD including smell tests.

Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8(6):329–339. https://doi.org/10.1038/nrneurol.2012.80 CrossRefPubMed

Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, Johnston AN, Mellick GD, Herting B, Reichmann H, Hummel T (2009) Prevalence of smell loss in Parkinson’s disease—a multicenter study. Parkinsonism Relat Disord 15(7):490–494. https://doi.org/10.1016/j.parkreldis.2008.12.005 CrossRefPubMed

Laska M, Distel H, Hudson R (1997) Trigeminal perception of odorant quality in congenitally anosmic subjects. Chem Senses 22(4):447–456CrossRefPubMed

Doty RL, Brugger WE, Jurs PC, Orndorff MA, Snyder PJ, Lowry LD (1978) Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 20(2):175–185CrossRefPubMed

Cain WS, Murphy CL (1980) Interaction between chemoreceptive modalities of odour and irritation. Nature 284(5753):255–257CrossRefPubMed

Boyle JA, Frasnelli J, Gerber J, Heinke M, Hummel T (2007) Cross-modal integration of intranasal stimuli: a functional magnetic resonance imaging study. Neuroscience 149(1):223–231. https://doi.org/10.1016/j.neuroscience.2007.06.045 CrossRefPubMed

Hummel T, Futschik T, Frasnelli J, Huttenbrink KB (2003) Effects of olfactory function, age, and gender on trigeminally mediated sensations: a study based on the lateralization of chemosensory stimuli. Toxicol Lett 140–141:273–280CrossRefPubMed

Iannilli E, Gerber J, Frasnelli J, Hummel T (2007) Intranasal trigeminal function in subjects with and without an intact sense of smell. Brain Res 1139:235–244. https://doi.org/10.1016/j.brainres.2006.12.082 CrossRefPubMed

Frasnelli J, Schuster B, Hummel T (2010) Olfactory dysfunction affects thresholds to trigeminal chemosensory sensations. Neurosci Lett 468(3):259–263. https://doi.org/10.1016/j.neulet.2009.11.008 CrossRefPubMed

10.

Rombaux P, Mouraux A, Keller T, Hummel T (2008) Trigeminal event-related potentials in patients with olfactory dysfunction. Rhinology 46(3):170–174PubMed

11.

Tremblay C, Durand Martel P, Frasnelli J (2017) Trigeminal system in Parkinson’s disease: a potential avenue to detect Parkinson-specific olfactory dysfunction. Parkinsonism Relat Disord 44:85–90. https://doi.org/10.1016/j.parkreldis.2017.09.010 CrossRefPubMed

12.

Darweesh SK, Verlinden VJ, Stricker BH, Hofman A, Koudstaal PJ, Ikram MA (2017) Trajectories of prediagnostic functioning in Parkinson’s disease. Brain 140(2):429–441. https://doi.org/10.1093/brain/aww291 CrossRefPubMed

13.

Ren Y, Yang L, Guo Y, Xutao M, Li K, Wei Y (2012) Intranasal trigeminal chemosensitivity in patients with postviral and post-traumatic olfactory dysfunction. Acta Otolaryngol 132(9):974–980. https://doi.org/10.3109/00016489.2012.663933 CrossRefPubMed

14.

Hummel T, Barz S, Lotsch J, Roscher S, Kettenmann B, Kobal G (1996) Loss of olfactory function leads to a decrease of trigeminal sensitivity. Chem Senses 21(1):75–79CrossRefPubMed

15.

Kobal G (1985) Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 22(2):151–163CrossRefPubMed

16.

Frasnelli Schuster B, Hummel T (2007) Interactions between olfaction and the trigeminal system: what can be learned from olfactory loss. Cereb Cortex 17(10):2268–2275. https://doi.org/10.1093/cercor/bhl135 CrossRefPubMed

17.

Tremblay C, Durand Martel P, Frasnelli J (2018) Chemosensory perception is specifically impaired in Parkinson’s disease. Parkinsonism Relat Disord. https://doi.org/10.1016/j.parkreldis.2018.08.002 CrossRefPubMed

18.

Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G (1997) Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson’s disease. Neurology 49(5):1424–1431CrossRefPubMed

19.

Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 62(5):436–446CrossRefPubMedPubMedCentral

20.

Guducu C, Taslica S, Cakmur R, Ozgoren M, Ikiz AO, Oniz A (2015) Assessing olfactory function in Parkinson’s disease via entropy analysis of chemosensory event related potentials. Tohoku J Exp Med 237(2):111–116. https://doi.org/10.1620/tjem.237.111 CrossRefPubMed

21.

Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18(5):467–486. https://doi.org/10.1002/mds.10459 CrossRefPubMed

22.

Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. https://doi.org/10.1002/mds.23429 CrossRefPubMed

23.

Ponsen MM, Stoffers D, Twisk JW, Wolters E, Berendse HW (2009) Hyposmia and executive dysfunction as predictors of future Parkinson’s disease: a prospective study. Mov Disord 24(7):1060–1065. https://doi.org/10.1002/mds.22534 CrossRefPubMed

24.

Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x CrossRefPubMed

25.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed

26.

Thurauf N, Gunther M, Pauli E, Kobal G (2002) Sensitivity of the negative mucosal potential to the trigeminal target stimulus CO(2). Brain Res 942(1–2):79–86CrossRefPubMed

27.

Ottoson D (1955) Analysis of the electrical activity of the olfactory epithelium. Acta Physiol Scand Suppl 35(122):1–83PubMed

28.

Scheibe M, Schmidt A, Hummel T (2012) Investigation of the topographical differences in somatosensory sensitivity of the human nasal mucosa. Rhinology 50(3):290–293. https://doi.org/10.4193/Rhino11.224 CrossRefPubMed

29.

Kobal G, Hummel C, Nuernberg B, Brune K (1990) Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions 29(3–4):342–359CrossRefPubMed

30.

Kobal G (1981) Elektrophysiologische untersuchungen des menschlichen geruchssinns. Thieme, Stuttgart

31.

Hummel T (2000) Assessment of intranasal trigeminal function. Int J Psychophysiol 36(2):147–155CrossRefPubMed

32.

Rombaux P, Huart C, Mouraux A (2012) Assessment of chemosensory function using electroencephalographic techniques. Rhinology 50(1):13–21. https://doi.org/10.4193/Rhino11.126 CrossRefPubMed

33.

Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243. https://doi.org/10.1007/s00405-006-0173-0 CrossRefPubMed

34.

Hummel T, Whitcroft K, Andrews P, Altundag A, Cinghi C, Costanzo R, Damm M, Frasnelli J, Gudziol H, Gupta N (2017) Position paper on olfactory dysfunction. Rhinology 54(Supplement 26):1–30. https://doi.org/10.4193/Rhin16.248 CrossRefPubMed

35.

Seiden AM (2004) Postviral olfactory loss. Otolaryngol Clin N Am 37(6):1159–1166. https://doi.org/10.1016/j.otc.2004.06.007 CrossRef

36.

Yamagishi M, Fujiwara M, Nakamura H (1994) Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology 32(3):113–118PubMed

37.

Leopold D (2000) A perplexing olfactory loss. Arch Otolaryngol Head Neck Surg 126(6):803CrossRefPubMed

38.

Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A, Hahner A, Reichmann H, Hummel T (2009) Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov Disord 24(6):906–914. https://doi.org/10.1002/mds.22464 CrossRefPubMed

39.

Pause BM, Krauel K (2000) Chemosensory event-related potentials (CSERP) as a key to the psychology of odors. Int J Psychophysiol 36(2):105–122CrossRefPubMed

40.

Olofsson JK, Nordin S (2004) Gender differences in chemosensory perception and event-related potentials. Chem Senses 29(7):629–637. https://doi.org/10.1093/chemse/bjh066 CrossRefPubMed

41.

Sung S, Vijiaratnam N, Chan DWC, Farrell M, Evans AH (2018) Pain sensitivity in Parkinson’s disease: systematic review and meta-analysis. Parkinsonism Relat Disord 48:17–27. https://doi.org/10.1016/j.parkreldis.2017.12.031 CrossRefPubMed

42.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O (2018) Pain in Parkinson’s disease: facts and uncertainties. Eur J Neurol 25(7):917–e969. https://doi.org/10.1111/ene.13624 CrossRefPubMed

43.

Iannilli E, Del Gratta C, Gerber JC, Romani GL, Hummel T (2008) Trigeminal activation using chemical, electrical, and mechanical stimuli. Pain 139(2):376–388. https://doi.org/10.1016/j.pain.2008.05.007 CrossRefPubMed

44.

Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211CrossRefPubMed

45.

Bohnen NI, Müller MLTM, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133(6):1747–1754. https://doi.org/10.1093/brain/awq079 CrossRefPubMedPubMedCentral

46.

Joshi N, Rolheiser TM, Fisk JD, McKelvey JR, Schoffer K, Phillips G, Armstrong M, Khan MN, Leslie RA, Rusak B, Robertson HA, Good KP (2017) Lateralized microstructural changes in early-stage Parkinson’s disease in anterior olfactory structures, but not in substantia nigra. J Neurol 264(7):1497–1505. https://doi.org/10.1007/s00415-017-8555-3 CrossRefPubMed

47.

Iannilli E, Stephan L, Hummel T, Reichmann H, Haehner A (2017) Olfactory impairment in Parkinson’s disease is a consequence of central nervous system decline. J Neurol 264(6):1236–1246. https://doi.org/10.1007/s00415-017-8521-0 CrossRefPubMed

48.

Moessnang C, Frank G, Bogdahn U, Winkler J, Greenlee MW, Klucken J (2011) Altered activation patterns within the olfactory network in Parkinson’s disease. Cereb Cortex 21(6):1246–1253. https://doi.org/10.1093/cercor/bhq202 CrossRefPubMed

49.

Kollndorfer K, Jakab A, Mueller CA, Trattnig S, Schopf V (2015) Effects of chronic peripheral olfactory loss on functional brain networks. Neuroscience 310:589–599. https://doi.org/10.1016/j.neuroscience.2015.09.045 CrossRefPubMed

50.

Daiber P, Genovese F, Schriever VA, Hummel T, Mohrlen F, Frings S (2013) Neuropeptide receptors provide a signalling pathway for trigeminal modulation of olfactory transduction. Eur J Neurosci 37(4):572–582. https://doi.org/10.1111/ejn.12066 CrossRefPubMed

51.

Schaefer ML, Bottger B, Silver WL, Finger TE (2002) Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli. J Comp Neurol 444(3):221–226. https://doi.org/10.1002/cne.10143 CrossRefPubMed

52.

Fournel A, Ferdenzi C, Sezille C, Rouby C, Bensafi M (2016) Multidimensional representation of odors in the human olfactory cortex. Hum Brain Mapp 37(6):2161–2172. https://doi.org/10.1002/hbm.23164 CrossRefPubMedPubMedCentral

Title: Specific intranasal and central trigeminal electrophysiological responses in Parkinson’s disease
Authors: Cécilia Tremblay
Rosa Emrich
Annachiara Cavazzana
Lisa Klingelhoefer
Moritz D. Brandt
Thomas Hummel
Antje Haehner
Johannes Frasnelli
Publication date: 01-12-2019
Publisher: Springer Berlin Heidelberg
Keywords: Smelling Disorder
Smelling Disorder
Parkinson's Disease
Published in: Journal of Neurology / Issue 12/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-019-09517-4

At a glance: The STEP trials

Springer Medicine

Specific intranasal and central trigeminal electrophysiological responses in Parkinson’s disease

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2019

Cognitive function and neuropathological outcomes: a forward-looking approach

Trajectories of brain remodeling in temporal lobe epilepsy

Alcohol-related peripheral neuropathy: a systematic review and meta-analysis

Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis

Early MRI predictors of prognosis in multiple sclerosis

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study